Sangamo BioSciences | SGMO - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
Alaunos Therapeutics USD 1.07M 215K 2023-06
Alnylam Pharmaceuticals USD -84.37M 166.42M 2026-09
Amgen USD 653M 94.99B 2026-09
Bayer EUR 675M 87M 2025-12
BioCryst Pharmaceuticals USD 21.71M 7.58M 2026-06
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Cipla INR 167.4M 2.9M 2026-09
Compugen USD 1.84M 485K 2026-06
CSL USD 215M 111M 2025-12
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Grifols EUR 156.07M 31.46M 2025-09
Ionis Pharmaceuticals USD 4M 14M 2026-09
J&J USD 43M 25M 2026-03
Karyopharm Therapeutics USD 12.55M 66K 2026-03
Merck USD 525M 46M 2026-06
Novartis USD 468M 6M 2026-09
Omeros USD 4.05M 5.16M 2024-09
Pfizer USD 662M 5M 2026-09
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR 222M 65M 2026-09
Sarepta Therapeutics USD 21.51M 205K 2026-06
Tectonic Therapeutic USD 237.03M 9.54M 2026-06
Ultragenyx Pharmaceutical USD 20M 2M 2026-09
Vertex Pharmaceuticals USD 36M 32.7M 2026-09